rubella virus vaccine, live - HPV-77 strain grown in dog-kidney culture
Trade name: Rubelogen
Vaccineapproved
Approved
Jul 1, 1969
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1960s
- Jul 1, 1969
Earliest FDA Approval
Indications
Approved for
Mechanism of action
- Rubella virusImmunity, active
Rubella virus immunity, active
Approval history
- approvedJul 1, 1969
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rubella virus vaccine, live attenuated
- rubelogen